A rare case of impending paradoxical embolism with a complex patent foramen ovale

2012 ◽  
Vol 10 (4) ◽  
pp. 138-140
Author(s):  
Yasuko Yamaura ◽  
Kikuko Obase ◽  
Nozomi Watanabe ◽  
Kenzo Fukuhara ◽  
Terumasa Koyama ◽  
...  
2020 ◽  
Vol 2020 ◽  
pp. 1-4
Author(s):  
Edgar Stroppa Lamas ◽  
Alan Vinicius Gamero Osti

Background. Splenic infarction is a rare clinical condition. It is generally attributed to hematologic, vascular, cardioembolic, and infectious diseases or trauma. Case Presentation. We describe a rare case in an otherwise asymptomatic 41-year-old overweight woman with acute abdominal pain. Imaging work-up revealed splenic infarction. Common etiologies were excluded. A transesophageal echocardiography (TEE) revealed a patent foramen ovale (PFO). The patient was sent to closure with good outcome. Conclusion. Paradoxical embolism due to PFO can be a cause of splenic infarction, and its investigation and subsequent closure may be considered when there are no other causative disorders.


2018 ◽  
Vol 16 (3) ◽  
pp. 152-153 ◽  
Author(s):  
Ka Man Fong ◽  
Shek Yin Au ◽  
Henry Jeffrey Yuen ◽  
Jack Ka Chung Shek ◽  
Kin Ming Yim ◽  
...  

2021 ◽  
Vol 22 (3) ◽  
pp. 232-234
Author(s):  
Şerif Ahmet Kandemir ◽  
Yakup Alsancak ◽  
Ahmet Seyfeddin Gürbüz ◽  
Mehmet Akif Düzenli

Author(s):  
Harsha S. Nagarajarao ◽  
Chandra P. Ojha ◽  
Archana Kedar ◽  
Debabrata Mukherjee

: Cryptogenic stroke and its relation to the Patent Foramen Ovale (PFO) is a long-debated topic. Recent clinical trials have unequivocally established the relationship between cryptogenic strokes and paradoxical embolism across the PFO. This slit-like communication exists in everyone before birth, but most often closes shortly after birth. PFO may persist as a narrow channel of communication between the right and left atria in approximately 25-27% of adults. : In this review, we examine the clinical relevance of the PFO with analysis of the latest trials evaluating catheter-based closure of PFO’s for cryptogenic stroke. We also review the current evidence examining the use of antiplatelet medications versus anticoagulants for stroke prevention in those patients with PFO who do not qualify for closure per current guidelines.


Author(s):  
Naim Mridha ◽  
Eloise Ward ◽  
Samual Hayman ◽  
Arun Dahiya ◽  
Sandhir Prasad

Sign in / Sign up

Export Citation Format

Share Document